Summary
Problem addressed: Oligonucleotide based therapeutics have emerged as a new drug discovery platform. A range of oligonucleotide based drug candidates are being evaluated in late stage clinical trials. Chemical modifications of natural unmodified oligonucleotides are required...
More information & hyperlinks
Web resources: | http://www.browngroupnucleicacidsresearch.org.uk |